HIV prevention cascades for injection and sexual risk behaviors among HIV-negative people who inject drug in Iran
Autor: | Mohammad Karamouzian, Monireh Faghir Gangi, Ali Mirzazadeh, Saharnaz Nedjat, Mostafa Shokoohi, Afarin Rahimi-Movaghar, Kamran Yazdani |
---|---|
Rok vydání: | 2019 |
Předmět: |
Drug
Adult Male Adolescent media_common.quotation_subject Human immunodeficiency virus (HIV) 030508 substance abuse Medicine (miscellaneous) Human sexuality HIV Infections Iran medicine.disease_cause Article 03 medical and health sciences 0302 clinical medicine Risk-Taking Environmental health Medicine Humans 030212 general & internal medicine Hiv acquisition Hiv treatment Cities Substance Abuse Intravenous Sexual risk media_common Drug injection Harm reduction business.industry Health Policy virus diseases Pharmaceutical Preparations Female 0305 other medical science business |
Zdroj: | Int J Drug Policy |
ISSN: | 1873-4758 |
Popis: | Background The HIV prevention cascade complements the HIV treatment cascade and helps evaluate the access to and use of harm reduction programs among HIV-negative individuals at risk for HIV, including people who inject drugs (PWID). This study aimed to estimate the HIV prevention cascades among PWID in Iran. Methods Using data from the 2014 national bio-behavioral surveillance survey, 2,391 PWID were recruited from 31 harm reduction facilities and through outreach efforts across 10 major cities. PWID aged ≥18 years who reported drug injection in the past year were interviewed, and information regarding their demographic characteristics, sexual and drug injection practices, and access to services were gathered. PWID were also tested for HIV infection. We examined the prevention cascade framework among HIV-negative PWID. Results The majority of PWID were male (97.6%) and more than half aged ≥ 35 years old (55.5%). Overall, 2,092 (92.5% [95% CI: 90.8, 93.9]) were HIV-negative; 93% of whom knew illicit drug injection could increase the risk of HIV transmission, 54% had access to free-of-charge sterile needles and syringes, 51% used sterile needles and syringes in their last injection practice, and 33% used sterile needles and syringes in all injection practices in the past month. Also, 87.8% (95% CI: 85.1, 90.0) of HIV-negative PWID had sex with any partner in the past year; 88% of whom knew using condoms could reduce the risk of HIV transmission, 35% had access to free-of-charge condoms, 32% used condoms in their last sexual practice, and 18% used condoms in all of their sexual practices in the past month. Conclusion The majority of HIV-negative PWID in Iran were at risk for HIV acquisition through unsafe drug injection or sexual practices. Harm reduction programs should improve access to free sterile needles, syringes, and condoms for PWID. |
Databáze: | OpenAIRE |
Externí odkaz: |